Tag: Arga Medtech
Argá Medtech reports 94% lesion durability and “strong safety profile” with...
Argá Medtech has announced positive clinical results from the BURST-AF first-in-human trial, demonstrating the safety, effectiveness and durability of its Coherent sine-burst electroporation (CSE)...
Argá Medtech announces first enrolments in COHERENT-AF IDE clinical trial
Argá Medtech has announced initial enrolments in the COHERENT-AF pivotal clinical trial. This US Food and Drug Administration (FDA) investigational device exemption (IDE), prospective,...